Many interferon (IFN)-stimulated genes are also induced by double-stranded RNA (dsRNA), a component closely associated with the IFN system in the context of virushost interactions. Recently, we demonstrated that the IFN-induced 3 0 -5 0 exonuclease ISG20 possesses antiviral activities against RNA viruses. Here we show that ISG20 induction by synthetic dsRNA (pIpC) is stronger and faster than its induction by IFN. Two families of transcription factors are implicated in the transcriptional activation of ISG20 by dsRNA. Initially, the NF-kB factors p50 and p65 bind and activate the kB element of the Isg20 promoter. This is followed by IRF1 binding to the ISRE. As pIpC often induces protein movements in the cells, we questioned whether it could influence ISG20 localization. Interestingly and contrary to IFN, dsRNA induces a nuclear matrix enrichment of the ISG20 protein. dsRNA induction of ISG20 via NF-kB and its antiviral activity led us to suggest that ISG20 could participate in the cellular response to virus infection.
Many interferon (IFN)-stimulated genes are also induced by double-stranded RNA (dsRNA), a component closely associated with the IFN system in the context of virushost interactions. Recently, we demonstrated that the IFN-induced 3 0 -5 0 exonuclease ISG20 possesses antiviral activities against RNA viruses. Here we show that ISG20 induction by synthetic dsRNA (pIpC) is stronger and faster than its induction by IFN. Two families of transcription factors are implicated in the transcriptional activation of ISG20 by dsRNA. Initially, the NF-kB factors p50 and p65 bind and activate the kB element of the Isg20 promoter. This is followed by IRF1 binding to the ISRE. As pIpC often induces protein movements in the cells, we questioned whether it could influence ISG20 localization. Interestingly and contrary to IFN, dsRNA induces a nuclear matrix enrichment of the ISG20 protein. dsRNA induction of ISG20 via NF-kB and its antiviral activity led us to suggest that ISG20 could participate in the cellular response to virus infection. Keywords: ISG20; dsRNA; NF-kB; IRF1; transcription; interferon Double-stranded RNA (dsRNA) is an important component of viral infection that stimulates host antiviral responses, including the production of cytokines like type I interferon (IFN) (Jacobs and Langland, 1996) . Recent studies show that a member of the interleukine-1/Toll receptor super-family, Toll-like receptor 3 (TLR3), recognizes dsRNA and induces the synthesis of more than 100 genes called dsRNAstimulated genes (DSGs) (Alexopoulou et al., 2001 ). Some of them are shown to be involved in the response of cells to viral infection (Geiss et al., 2001) . Interestingly, several DSGs are also induced by IFNs, indicating that IFNs and dsRNA stimulate the transcription of partially overlapping set of genes. dsRNA is also the activator of two enzymes of the IFN system: the dsRNA-activated serine-threonine proteine kinase (PKR) and the 2 0 ,5 0 oligoadenylate synthetase (2,5 OAS) that activates the dormant endoribonuclease RNaseL. When activated, PKR and RNaseL inhibit translation and activate apoptosis, leading to a strong antiviral effect (Samuel, 2001) . The dsRNA signalling pathway activates several transcription factors such as NF-kB and IRF-1, -3 and -7 (Williams, 1999) . Activation of these factors is mediated by protein kinases including PKR, p38, JNK and IKK, but the activation pathways are not completely understood. Moreover, evidence for a role of PKR in NF-kB activation is controversial. Iordanov et al. have suggested that PKR is only required for dsRNA-mediated inhibition of hostcell protein synthesis but not for NF-kB activation in response to dsRNA or virus infection (Iordanov et al., 2000) . On the other hand, dsRNA and viruses can also activates a 'virus activated kinase' (VAK), which is responsible for phosphorylation of the transcription factors IRF-3 and IRF-7. This modification permits IRF activation and dimerization, leading to their nuclear translocation and direct activation of target genes carrying IFN-stimulated responsive element (ISRE) on their promoters. Two groups recently reported that the IkB kinase (IKK)-related kinases IKKe and TANK-binding kinase 1 are components of VAK (Fitzgerald et al., 2003; Sharma et al., 2003) . IRF-3 and NF-kB can also be concomitantly activated in response to the binding of extracellular dsRNA to TLR3 (Doyle et al., 2002) . ISG20 is a 3 0 -5 0 exonuclease whose gene is transcriptionally induced by both types I and II IFN (Gongora et al., 1997 (Gongora et al., , 2000 Nguyen et al., 2001) . Its induction by IFN is strictly dependent upon the activation and the binding of IRF1 to a specific ISRE on the Isg20 promoter. Moreover, the TATA-less Isg20 promoter contains one E-box and putative NF-kB and Sp1 binding sites suggesting that it could be induced by other stimuli. We have recently shown that ISG20 possesses high antiviral activity against VSV infection, even in a PKR/RNaseL/Mx null background (Espert et al., 2003) . This result indicates that ISG20 participates in the IFN-induced antiviral state. As ISG20 has a putative NF-kB site in its promoter, we asked whether it could be directly induced by dsRNA. To test this hypothesis, we performed a Western blot analysis using protein extracts from HeLa cells treated for various lengths of time with type I IFN or synthetic dsRNA (pIpC). As shown in Figure 1a and b, a low level of ISG20 was detected in nontreated HeLa cells. Addition of pIpC resulted in a marked increase in ISG20 protein level as early as 4 h after stimulation that lasted for over 24 h (Figure 1a) . In contrast to pIpC-stimulated cells, a slower and weaker induction of ISG20 was observed in type I IFN-treated cells (Figure 1b) . These results suggest that the increase of ISG20 is not a consequence of dsRNA-induced IFN secretion since it occurred faster. To confirm this hypothesis, we treated HeLa cells with pIpC for 4 and 8 h in the presence of neutralizing antitype I IFN antibodies in the culture medium. As can be seen in Figure 1c , the anti-IFN antibodies abolished the induction of ISG20 by IFN, without affecting induction by dsRNA. Thus, ISG20 induction by dsRNA seems to be direct and not mediated by IFN secretion. This observation suggests that antiviral ISG20 protein can participate in an innate antiviral mechanism representing the first line of cellular defense.
As dsRNA can induce a delocalization of some proteins, we next wanted to know if pIpC could induce ISG20 subcellular relocalization. To this end, HeLa cells were treated with either type I IFN or pIpC for 16 h. We separated the protein extracts into cytoplasm (C), RIPA soluble nuclear (R) and RIPA insoluble fractions (P) and analysed ISG20 expression by Western Blotting. ISG20 was found to be present in both the cytoplasm and the nucleoplasm at a basal level. The pattern of localization of ISG20 is not modified in cells treated with type I IFN compared to the control cells ( Figure 1d ). Interestingly, in contrast, upon pIpC induction, we observed the presence of the ISG20 protein in the RIPA-insoluble fraction, representing the nuclear matrix (NM) (Figure 1d ). Moreover, we showed that the transfer of ISG20 to the NM occurred as early as 4 h after pIpC induction (Figure 1e ). These results show that ISG20 possesses distinct localizations in the cell, depending on its inducer. As pIpC mimics viral infection, this result also suggests that ISG20 could be activated by moving to the NM. It is known that stress can mediate the transfer of some proteins, like p53, from soluble phase to NM (Roti Roti et al., 1997; Okorokov et al., 2002) . Moreover, it is shown that dsRNA induces the two SAPK, p38 and JNK, indicating that dsRNA could be considered as a stress for the cell. Some preliminary data suggest that p38 and JNK are involved in dsRNA induction of ISG20 (data not shown), suggesting that ISG20 could be involved in the cellular stress response.
To further characterize the molecular mechanism of ISG20 induction by dsRNA, we analysed the Isg20 promoter region to identify sequence elements and trans-acting factors implicated. Transcriptional signals generated by dsRNA are known to be perceived, at least Exponentially growing cells were treated with 100 mg/ml of pIpC (Amersham Pharmacia Biotech) or (b) 500 u/ml of human (Hu) type I IFN (intron A, Schering-Plough) for various times. Cells were lysed in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1% NP40, 10% Glycerol, 1 mM PMSF, 5 mM NaF, antiproteases cocktail. An amount of 40 mg of total protein extract was analysed by Western blotting with a polyclonal rabbit antiserum against ISG20 (described (by Espert et al., 2003) ). Detection of a-tubulin (sigma) was used as control of equivalent loading. (c) Neutralizing antihuman type I IFN antibodies (gift from Dr I Gresser and Dr K Mogensen) were added 1 h prior to the pIpC treatment. Cells were then treated with 100 mg/ml of pIpC during 4 and 8 h. As a control of anti-IFN efficiency, cells were treated with these antibodies and then treated with human type I IFN during 16 h. An amount of 20 mg of total protein extract was analysed by Western-blotting with polyclonal Ab anti-ISG20. (d) HeLa cells were either treated with 500 u/ml of Hu type I IFN or 100 mg/ml of pIpC for 16 h. To obtain cytoplasmic fraction (C), cells were suspended in 0.25% NP40. Pellet was suspended in RIPA buffer as described in Zhu et al. (1997) to separate the nucleoplasm (R: RIPA soluble) from the nuclear matrix (P as pellet: RIPA insoluble). Fractionated cell extracts were separated on 12% SDS-PAGE. The presence of ISG20 in these three fractions was detected by Western blotting. (e) ISG20 appears in the nuclear matrix as soon as 4 h after pIpC treatment. Cells were treated with 100 mg/ml of pIpC for various lengths of times, and ISG20 was detected by Western blotting ISG20 is directly induced by synthetic dsRNA L Espert et al in part, by the NF-kB and ISRE sites present in the responsive genes. To examine the role of these sites in ISG20 induction, we used the ISG20 luciferase reporter constructs described in Figure 2a . HeLa cells were transfected with these six constructs, treated or not with pIpC for 4 h and then analysed for luciferase activity. Cells transfected with p460 and treated with pIpC exhibited a higher luciferase activity compared with untreated cells (Figure 2b ). The level of induction was small (two fold) but highly reproducible and can probably be explained by the short induction time that we tested (4 h) and also by the fact that long dsRNA strongly and nonspecifically reduced luciferase gene expression (up to 200 times) (Elbashir et al., 2001) . p358, corresponding to the deletion of the GAS site, shared an increase in luciferase activity similar to that of p460, indicating that GAS is not implicated in dsRNA induction of ISG20. No increase was observed in smaller constructs (p319, p178, p128 and p68), in which the NF-kB site was deleted, indicating that the NF-kB site is absolutely required for dsRNA induction of ISG20. However, on the basis of these results we were not able to determine the role of the other cis-acting site present in the Isg20 gene, especially the ISRE. To address this point, we performed site-directed mutagenesis of the ISRE and/or NF-kB sites (constructions presented in Figure 3a) . We tested Isg20 promoter activity in HeLa cells transfected with these constructs. Mutation of the NF-kB site of the Isg20 promoter completely inhibited induction by dsRNA, as soon as 4 h post-treatment (Figure 3b, lane 2) , and lasted as long as 8 h (Figure 3c, lane 2) . These data are in accordance with results obtained with constructs deleted for the NFkB site (Figure 2b ) and confirm that NF-kB is required for ISG20 induction by dsRNA. Interestingly, when the ISRE sequence was mutated, the reporter gene remained equally expressed after 4 h of dsRNA treatment (Figure 3b, lane 3 ), but returned to basal level at 8 h postinduction (Figure 3c, lane 3) . This finding suggests that in contrast to NF-kB, the ISRE element is only involved in the delayed response to dsRNA. As Figure 2 Cis-acting elements implicated in Isg20 promoter activity in response to pIpC. (a) Schematic representation of the 5 0 -end deletion mutants of the Isg20 promoter. The different constructs were cloned in the pGL3 basic vector as described in Gongora et al. (2000) . (b) HeLa cells were transfected with the different promoter constructs using lipofectamine and treated with 100 mg/ml of pIpC for 4 h. Luciferase activity was analysed using the Luciferase Reporter Gene Assay Kit (Roche). In each case, the relative luciferase activities were calculated using nontreated cells transfected with the same construct as a reference to detect the luciferase induction by pIpC. Each experiment was performed in duplicate; the standard deviations correspond to four distinct experiments for ISRE site mutation (in bold are the mutated bases). Appropriate PCR products were subsequently cloned into the pGL3 vector to generate pCiNeo-p460-Mut-NF-kB, pGL3-p460-Mut-ISRE and pGL3-p460-double-mut. HeLa cells were transfected with the four constructs and selected by G418 in order to obtain stable population. The different stable cell lines were treated with 100 mg/ml of pIpC for 4 (b) and 8 h (c), then analysed for luciferase activity. In each case, the relative luciferase activities were calculated using the same nontreated stable cell line as reference to detect the luciferase induction by pIpC. Each experiment was realized in duplicate; the standard deviations correspond to four distinct experiments ISG20 is directly induced by synthetic dsRNA L Espert et al expected, the p460-double-Mut construct completely lost inducibility by dsRNA (Figure 3b and c, lane 4) . Thus, ISG20 induction by dsRNA could be the result of a biphasic effect: first activation of the NF-kB element and then that of the ISRE. Our results are in accordance with the literature since it has been shown for other genes that dsRNA induction is attributed to synergistical action of specific transcription factors onto NF-kB and ISRE site (Mori et al., 2001; Blair et al., 2002) . Next, we investigated the nature of the transcription factors responsible for ISG20 dsRNA induction. We performed DNA affinity binding assays, using two Isg20 promoter specific DNA probes, including the NF-kB or ISRE sites, respectively (shown in Figure 4a ). These DNA probes were immobilized on magnetic beads and incubated with nuclear extracts from HeLa cells treated with dsRNA for various times. Bound material was analysed by immunoblot. As regards the NF-kB site, as shown in Figure 4b , lanes 6-8, only p65 and p50 were bound to the NF-kB site. Binding occurred as early as 15 min after dsRNA treatment and lasted for at least 4 h. Although present in the nuclear extracts (Figure 4b , input lanes), RelB did not bind to the DNA probe 1. An excess of free probe 1 inhibited binding of p65 and p50 to the immobilized probe (Figure 4b , lane 10), indicating that p50 and p65 bound specifically to the Isg20 promoter after dsRNA treatment. By EMSA we determined that the homodimer p65 and the heterodimer p50/p65 were present on the Isg20 promoter (data not shown).
IRF-1, -3 and -7 are known to bind ISRE after dsRNA induction (Bandyopadhyay et al., 1995; Behr et al., 2001) . The amount of IRF-1 bound to the ISRE probe (Probe 2) was markedly increased only after 4 h of dsRNA treatment (Figure 4b, lane 8) . On the contrary, despite its presence in the protein extract and its dsRNA-induced nuclear translocation (input lanes, Figure 4b) , IRF-3, did not bind to the ISRE. The same data were obtained for IRF7 (data not shown). The free ISRE probe completely titrated IRF1 binding to the bound probe (Figure 4b, lane 10) . These results show that among the IRF tested, only IRF1 bound to the Isg20 ISRE after dsRNA treatment and that the binding occurred later than the binding of p50 and p65 on the NF-kB site. These results are in accordance with the luciferase experiments (Figure 3b and c), indicating that ISG20 induction is the result of a biphasic mechanism involving first p65 and p50 binding on NF-kB and then IRF1 binding on ISRE of the Isg20 promoter. Cooperation between IRF1 and NF-kB has been previously reported for virus induction of MHC I, but no kinetic data have been reported (Ten et al., 1993) , indicating that we present this biphasic effect for the first time. Moreover, Saura et al, demonstrated that IRF-1 and NF-kB can interact in vivo, allowing the formation of an 'enhanceosome-like structure', where the absence of one of these two transcription factors may completely inhibit the target gene expression (Saura et al., 1999) . Our data in Figure 3c completely fit this hypothesis as shown by the fact that the mutation of NF-kB or ISRE site inhibit ISG20 promoter inducibility after 8 h of dsRNA induction.
It is interesting to note that Hummer et al. (2001) demonstrated that induction of IRF1 by dsRNA is p53 dependent in HeLa cells expressing temperature-sensitive p53. As ISG20 induction is dependent on IRF1, it should be interesting to test in the same cell line if p53 is involved in dsRNA induction of ISG20. The tumor suppressor p53 is known to act either as protective or apoptotic protein in response to genotoxic stress (Amundson et al., 1998) . Thus, its implication in dsRNA signalling could drive the cell toward survival or death. Similarly, two distinct pathways are involved in the dsRNA cell response (Kaufman, 1999; Kehoe et al., 2001; Peters et al., 2002) : (1) dsRNA activates antiviral proteins like PKR or RNase L in order to decrease host-cell protein synthesis and thus prevent viral replication. In addition, this pathway contributes to the elimination of infected cells by apoptosis (DiazGuerra et al., 1997; Samuel, 2001) . (2) The second dsRNA pathway is the induction of type I IFN secretion in order to alert neighbor cells of the viral invasion (Iordanov et al., 2001) . The latter pathway requires survival of the infected cell and depends on the expression of antiapoptotic genes through the activation of NF-kB. The two pathways are independent as shown Figure 4 Trans-acting factors implicated in Isg20 promoter activity after the pIpC induction. (a) Schematic representation of the Isg20 promoter probes used (sequences available on request). (b) Nuclear extracts from HeLa cells were prepared as described in Gongora et al., (2000) . For the DNA affinity binding assay, the two probes were amplified by PCR with a biotinylated 5 0 primer (sequences available on request). Amplified DNA was bound to M280 magnetic beads (Dynal) and incubated with nuclear extracts for 1 h at 41C. Beads were washed with washing buffer (20 mM Tris, pH7.9, 5 mM MgCl 2 , 0.2 mM EDTA, 100 mM NaCl) and bound materials were eluted and separated by 10% SDS-PAGE. Western blotting was performed to detect DNA-bound proteins with polyclonal rabbit antisera against IRF-1 (sc-497), p50 (sc-7178), p65 (sc-372) and IRF-3 (sc-9082) obtained from Santa Cruz Biotechnology. Polyclonal rabbit antisera against RelB was a gift from Dr M Benkirane. Input represents 5% of total extract. A competition experiment using excess NF-kB or ISRE probes was performed to attest to the relevance of the interactions (FT: flow through) ISG20 is directly induced by synthetic dsRNA L Espert et al by the fact that in the absence of PKR and RNase L, NF-kB is activated by dsRNA and type I IFN secretion is induced normally (Iordanov et al., 2001 ).
As we have recently shown, the ISG20 protein possesses an antiviral activity against VSV infection (Espert et al., 2003) . Now we show that ISG20 is highly induced by dsRNA in a NF-kB-dependent manner. These results suggest that ISG20 could participate in the antiapoptotic program of innate antiviral immunity, which proceeds through the activation of NF-kB and which is independent of the presence of PKR. The fact that ISG20 is still induced by dsRNA in PKR/RNaseL/ Mx triply deficient cells (data not shown) suggests that ISG20 acts independently from PKR. In other words, ISG20 may belong to the second antiviral pathway, implicating the survival of the infected cell.
Finally, specific association of ISG20 with NM only after induction by dsRNA may be connected with its antiviral activity. Indeed, NM is an important site of viral-host cell interactions (Deppert, 2000) , so the association of ISG20 with the NM suggests that its effect on viruses could occur specifically in this compartment. Hence, dsRNA seems to be the obligatory activator of ISG20 antiviral activity, as is the case for some other antiviral IFN-induced proteins like PKR. Cancer Comite 0 s de l 0 Herault et du Gard, and the Fondation pour la Recherche Me 0 dicale. LE was Funded by Fellowship from Ensemble contre le SIDA.
